Merkel cell carcinoma with partial spontaneous regression: An immunohistochemical, ultrastructural, and TUNEL labeling study

American Journal of Dermatopathology

Volumn 19, Issue 6, 1997, Pages 614-618

  Takenaka, Hideya ^a   Kishimoto, Saburo ^a   Shibagaki, Ryo ^a   Nagata, Makoto ^a   Yasuno, Hirokazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Apoptosis; Merkel cell carcinoma; Spontaneous regression; TUNEL

Indexed keywords

AGED; APOPTOSIS; ARTICLE; CANCER REGRESSION; CASE REPORT; CELL ULTRASTRUCTURE; CELLULAR IMMUNITY; DNA STRAND BREAKAGE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MERKEL CELL TUMOR; PRIORITY JOURNAL;

AGED; APOPTOSIS; BIOPSY; CARCINOMA, MERKEL CELL; FEMALE; GENETIC TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM REGRESSION, SPONTANEOUS; SKIN; SKIN NEOPLASMS;

EID: 0030730091     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199712000-00012     Document Type: Article

References (14)

1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol 1972;105:107-10.
2. Hitchcock CL, Bland KI, Laney RG III, Franzini D, Harris B, Copeland EMIII. Neuroendocrine (Merkel cell) carcinoma of the skin: its natural history, diagnosis, and treatment. Ann Surg 1988;207:201-7.
3. O'Rourke MGE, Bell JR. Merkel cell tumor with spontaneous regression. J Dermatol Surg Oncol 1986;12:994-7.
4. Kayashima K, Ono T, Johno M, Kojo Y, Yamashita N, Matsunaga W. Spontaneous regression in Merkel cell (neuroendocrine) carcinoma of the skin. Arch Dermatol 1991;127:550-3.
5. Duncan WC, Tschen JA. Spontaneous regression of Merkel cell (neuroendocrine) carcinoma of the skin. J Am Acad Dermatol 1993;29:653-4.
6. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
7. Kishimoto S, Nagata M, Takenaka H, Yasuno H. Detection of apoptosis by in situ labeling in pilomatricoma. Am J Dermatopathol 1996;18:339-43.
8. Cole WH. Efforts to explain spontaneous regression of cancer. J Surg Oncol 1981;17:201-9.
9. Smith JL, Stehlin JS. Spontaneous regression of primary nielanomas with regional metastases. Cancer 1965;18:1399-415.
10. Little JH. Partial regression in primary cutaneous malignant melanoma. Pathology 1971;3:62.
11. Curson C, Weedon D. Spontaneous regression in basal cell carcinomas. J Cutan Pathol 1979;6:432-7.
12. Ferradini L, Maekensen A, Genevee C, Hosq J, Duvillard P, Avril MF, Hercend T. Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. J Clin Invest 1993;91:1183-90.
13. Mackensen A, Ferradini L, Carcelain G, Triebel F, Faure F, Viel S, Hercend T. Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma. Cancer Res 1993;53:3569-73.
14. Kurt RA, Park JA, Panelli MC, Schluter SF, Marchalonis JJ, Carolus B, Akporiaye ET. T lymphocytes infiltrating sites of tumor rejection and progression display identical Vβ usage hut different cytotoxic activities. J Immunol 1995;154:3969-74.